Table 1 Previously reported cases of giant cell tumor of the larynx
From: A large giant cell tumor of the larynx: case report and review of the literature
Case | Year | Author | Age | Sex | Location | Size (cm) | Treatment |
|---|---|---|---|---|---|---|---|
1 | 1940 | Wessely [1] | 51 | Male | Cricoid | RT | |
2 | 1951 | Federova [2] | 35 | Male | Thyroid | PL + RT | |
3 | 1952 | Wagemann [3] | 40 | Male | Cricoid | TL + RT | |
4 | 1958 | Perrino [4] | 32 | Male | Cricoid | TE via LF + RT | |
5 | 1966 | Kaliteevskii and Korol’kova [5] | 52 | Male | Thyroid | 5 | TL |
6 | 1968 | Pohl [6] | 50 | Male | Thyroid | RT | |
7 | 1969 | Kohn [1] | 50 | Male | Epiglottis | ||
8 | 1971 | Rudert [7] | 53 | Male | Thyroid | PL | |
9 | 1972 | Hall-Jones [8] | 26 | Male | Thyroid | 5.5 | TL |
10 | 1973 | Goto and Nakashima [9] | 47 | Male | Thyroid | TE | |
11 | 1974 | Kotarba and Niezabitowski [10] | 60 | Male | Epiglottis | 3 | PL |
12 | 1975 | Ribari et al. [11] | 35 | Male | Cricoid | “Walnut” | TE via LF + RT |
13 | 1976 | Kubo et al. [12] | 40 | Male | Cricoid | 2.2 | TE via LF + RT + 5 FU |
14 | 1988 | Borghese et al. [1] | 28 | Male | Thyroid | TE via LF | |
15 | 1992 | Badet et al. [13] | 55 | Female | Cricoid | TL | |
16 | 1993 | Murrell and Lantz [14] | 42 | Male | Thyroid | 4 | TL |
17 | 1994 | Martin et al. [15] | 23 | Male | Thyroid | 4 | PL |
18 | 1994 | Miyata et al. [16] | 60 | Male | Thyroid | 3 | TL |
19 | 1997 | Werner et al. [17] | 35 | Male | Thyroid | 4.8 | TL |
20 | 1997 | Paik et al. [18] | 39 | Male | Thyroid | 5 | TL |
21 | 2000 | Hinni [19] | 31 | Male | Thyroid | 4 | PL |
22 | 2001 | Wieneke et al. [20] | 37 | Male | Thyroid | 4.2a | RT + Cytoxan + TL |
23 | 2001 | Wieneke et al. [20] | 37 | Male | Cricoid | 4.2a | PL |
24 | 2001 | Wieneke et al. [20] | 40 | Male | Thyroid | 4.2a | PL |
25 | 2001 | Wieneke et al. [20] | 44 | Male | Thyroid | 4.2a | TL |
26 | 2001 | Wieneke et al. [20] | 53 | Female | Thyroid | 4.2a | PL |
27 | 2001 | Wieneke et al. [20] | 57 | Male | Cricoid | 4.2a | RT |
28 | 2001 | Wieneke et al. [20] | 62 | Female | Thyroid | 4.2a | TL |
29 | 2004 | Wong and Seikaly [21] | 49 | Male | Thyroid | 4 | PL |
30 | 2007 | Nishimura et al. [22] | 31 | Male | Thyroid | 4 | PL |
31 | 2007 | Chang et al. [23] | 53 | Male | Thyroid | ||
32 | 2008 | Zheng-Ping et al. [24] | 53 | Male | Thyroid | 3 | PL |
33 | 2012 | Le et al. [25] | 39 | Male | Thyroid | 5 | PL |
34 | 2013 | Derbel et al. [26] | 38 | Male | Thyroid | 4 | Denosumab + PL |
35 | 2013 | Lv et al. [27] | 65 | Male | Thyroid | 4 | PL |
36 | 2013 | Vivero et al. [28] | 34 | Male | Thyroid | 4.5 | PL + Chemotherapy |
37 | 2014 | Chunling et al. [29] | 39 | Male | Thyroid | 3.6 | TE |
38 | 2014 | Leon-Medina et al. [30] | 40 | Male | Thyroid | 1.5 | TL |
39 | 2014 | Nota et al. [31] | 59 | Male | Thyroid | 3 | TL |
40 | 2015 | Swanson and Brown [32] | 76 | Female | Cricoid | 1 | TE |
41 | 2015 | Yancoskie et al. [1] | 46 | Male | Thyroid | 4.5 | PL + Denosumab |
42 | 2016 | Lida et al. [33] | 53 | Male | Thyroid | 4.6 | TL |
43 | 2016 | Present case | 31 | Male | Thyroid | 5.7 | TL |